Ross A. Baker
Impact in
- Psychiatry and Mental health top 0.5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
Papers in
-
- Schizophrenia research and treatment 50
- Bipolar Disorder and Treatment 13
- Pharmacology 22
- Treatment of Major Depression 21
- Co-authors
- V M Sanders (2 shared papers)Timothy S. Peters-Strickland (23 shared papers)Richard L. Saint Marie (1 shared paper)Anna Eramo (28 shared papers)Robert D. McQuade (20 shared papers)Deborah J. Kasprowicz (1 shared paper)Nancy E. Street (1 shared paper)B A Fuchs (1 shared paper)
- Journals
- Schizophrenia Research (8 papers)International Clinical Psychopharmacology (6 papers)Journal of Clinical Psychopharmacology (6 papers)Journal of Medical Economics (5 papers)The Journal of Clinical Psychiatry (5 papers)
- Partner nations
- United StatesDenmarkSpain
In The Last Decade
Ross A. Baker
106 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 114
- Psychiatry and Mental health 1.7k
- Biological Psychiatry 146
- Behavioral Neuroscience 169
- Sensory Systems 157
- Pharmacology 437
Countries citing papers authored by Ross A. Baker
This map shows the geographic impact of Ross A. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross A. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross A. Baker more than expected).
Fields of papers citing papers by Ross A. Baker
This network shows the impact of papers produced by Ross A. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross A. Baker. The network helps show where Ross A. Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Ross A. Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 365 | |
| 2 | 1997 | 185 | |
| 3 | 1990 | 160 | |
| 4 | 2009 | 155 | |
| 5 | 2014 | 126 | |
| 6 | 2017 | 126 | |
| 7 | 2015 | 123 | |
| 8 | 2007 | 120 | |
| 9 | 2019 | 113 | |
| 10 | 2014 | 86 | |
| 11 | 2008 | 72 | |
| 12 | 2016 | 58 | |
| 13 | 2012 | 57 | |
| 14 | 2016 | 55 | |
| 15 | 2014 | 43 | |
| 16 | 2013 | 41 | |
| 17 | 2011 | 39 | |
| 18 | 2013 | 39 | |
| 19 | 1991 | 39 | |
| 20 | 2006 | 37 |
About Ross A. Baker
Ross A. Baker is a scholar working on Psychiatry and Mental health, Pharmacology, Pediatrics, Perinatology and Child Health, Endocrinology, Diabetes and Metabolism and Experimental and Cognitive Psychology, having authored 107 papers that have together received 3.3k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (50 papers), Treatment of Major Depression (21 papers), Bipolar Disorder and Treatment (13 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical studies and practices (3 papers), Prenatal Substance Exposure Effects (3 papers), Healthcare Decision-Making and Restraints (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Psychiatry and Mental health (1.7k citations), Biological Psychiatry (146 citations), Behavioral Neuroscience (169 citations), Sensory Systems (157 citations) and Pharmacology (437 citations). Ross A. Baker has collaborated with scholars based in United States, Denmark and Spain. Frequent co-authors include V M Sanders, Timothy S. Peters-Strickland, Richard L. Saint Marie, Anna Eramo, Robert D. McQuade, Deborah J. Kasprowicz, Nancy E. Street, B A Fuchs, Quynh-Van Tran and Richard E. Whitehead. Their work appears in journals such as Schizophrenia Research, International Clinical Psychopharmacology, Journal of Clinical Psychopharmacology, Journal of Medical Economics and The Journal of Clinical Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.